Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.03 - Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6
10:50 - 11:00 | Presenter: Sai-Hong Ignatius Ou | Author(s): Alice T. Shaw, Gregory J Riely, Rita Chiari, Jessica R. Bauman, Jill S. Clancy, Holger Thurm, Gerson Peltz, Antonello Abbattista, Ben J Solomon
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-74 - MET Exon 14-Altered Lung Cancers: Central Nervous System (CNS) Metastases and Patterns of CNS Progression on MET Inhibition.
16:45 - 18:00 | Presenter: Michael Offin | Author(s): Jordan Dienstag, Olivia Wilkins, Joshua K Sabari, Ai Ni, Daniel L. Feldman, Martine Van Voorthuysen, Ken Suzawa, Helena Yu, Gregory J Riely, Maria E Arcila, Marc Ladanyi, Mark G Kris, Charles M. Rudin, Romel Somwar, Bob T. Li, Alexander Drilon
- Abstract
Loading... -
+
P1.01-75 - Utility of cfDNA Testing for Acquired Resistance: The Memorial Sloan Kettering Experience with Plasma EGFR T790M Clinical Testing.
16:45 - 18:00 | Presenter: Michael Offin | Author(s): Mackenzie Myers, Sowmya Josyula, Ronglai Shen, Laetitia Borsu, Dana Tsui, Gregory J Riely, Charles M. Rudin, Helena Yu, Bob T. Li, Maria E Arcila
- Abstract
Loading... -
+
P1.01-81 - Phase 3 Study of Pemetrexed-Platinum with or without Pembrolizumab for TKI-Resistant/EGFR-Mutated Advanced NSCLC: KEYNOTE-789
16:45 - 18:00 | Presenter: Gregory J Riely | Author(s): Rina Hui, David P Carbone, Keunchil Park, Marion Carrigan, Xia Xu, Thao Dang, James Chih-Hsin Yang
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-44 - Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
16:45 - 18:00 | Presenter: Joel W. Neal | Author(s): Robert C. Doebele, Gregory J Riely, Alexander Spira, Leora Horn, Zofia Piotrowska, Daniel B Costa, Steven Zhang, Dean Bottino, Jian Zhu, David Kerstein, Shuanglian Li, Pasi A Jänne
- Abstract
Loading...
-
+
SH02 - Highlight of the Previous Day Sessions
- 07:00 - 08:00
- 9/25/2018
- Location: Room 202 BD
- Type: Highlight of the Day Session
- Track:
-
+
SH02.03 - IO
07:24 - 07:36 | Presenter: Gregory J Riely
- Abstract
No abstract available for this presentation
-
+
MA19 - Genomic Markers of IO Response
- 15:15 - 16:45
- 9/25/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA19.09 - Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB
16:10 - 16:15 | Presenter: Kathryn C Arbour | Author(s): Ronglai Shen, Andrew Plodkowski, Hira Rizvi, Ai Ni, Niamh Long, Darragh Halpenny, Francisco Sanchez-Vega, Charles M. Rudin, Gregory J Riely, Matthew D. Hellmann
- Abstract
Loading...
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.02 - Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
15:25 - 15:35 | Presenter: Alexander Drilon | Author(s): Jeffrey W. Clark, Jared Weiss, Sai-Hong Ignatius Ou, Ross Camidge, Ben J Solomon, Gregory A. Otterson, Liza Villaruz, Gregory J Riely, Rebecca Heist, Geoffrey I. Shapiro, Danielle A. Murphy, Sherry C. Wang, Tiziana Usari, Sherry Li, Keith D. Wilner, Paul K. Paik
- Abstract
Loading...